MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND--(Marketwire - June 25, 2008) - Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that it has received a letter from the New Zealand Minister of Health, the Honorable David Cunliffe, indicating that he has sought independent advice from the National Health Committee (NHC) by 8 August 2008, on LCT's application to conduct a Phase I/IIa clinical trial with DiabeCell® in New Zealand.
